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It has been shown previously that antisera raised in (A  X B)  F~ animals (whereby 
A  and B  designate two strains of inbred rats)  against alloantibodies A  anti-B are 
capable of specifically  blocking the recognition of B antigens by A lymphoid cells (1). 
The test system used to measure antigenic recognition in vitro was the PAR (product 
of antigenic recognition) assay (2), basically a short-term mixed lymphocyte culture. 
The anti-receptor activity of such anti-alloantibodies was  indistinguishable, by this 
test, from that of sera induced in (A X B)F~ rats by the injection of receptor-bearing 
parental strain lymphoid cells. This led to the conclusion that  receptors  present on 
lymphoid cells and those presumed to exist in the antigen-combining  region of allo- 
antiserum might be antigenically  similar (1). 
The  existence  of  antibodies specifically directed  against recognition struc- 
tures  (RS) 1 on lymphoid cells bears on fundamental aspects  of immunology; 
it  therefore seemed useful to  seek confirmation by experiments entireh, inde- 
pendent of the PAR test. The most straightforward approach appeared to be a 
demonstration of  the  uptake  of  radioactively labeled  anti-alloantibodies by 
lymphoid cells.  This  uptake  should  occur preferentially by  those  cells  pre- 
sumed to carry receptors of similar combining specificity to  the  alloantibody 
against which  the  labeled  anti-alloantibody was  directed.  The  present  com- 
munication shows that this premise was sustained. 
Materials and Methods 
Animals.--Rats of the following inbred strains were domestically maintained: Lewis, DA, 
and BN. Adults of either sex were used in the experiments. F1 hybrids were raised as required. 
Alloantisera.--Full-thickness  skin grafts were performed from one rat strain to another 
(3). These grafts were rejected within 9-11 days. 3 wk after a single skin graft, animals were 
bled, and the serum was heated at 56°C for 30 min, Millipore filtered (Millipore Corp., Bed- 
ford, Mass.), and stored at --20°C. 
Anti-Alloantisera.--Alloantiseruln,  for instance of specificity DA anti-Lewis, was injected 
into (DA X Lewis)F1  animals. On day 0, each animal to be immunized received 10 intradermal 
injections of 0.1 ml of plain alloantiserum distributed over the skin of the back (1). On day 14, 
animals were bled and the serum pool was inactivated and Millipore filtered as described for 
alloantisera. The alloantisera serving as antigens, the hybrids immunized, and the specificity 
of the anti-alloantisera obtained are shown in Table I. 
1  Abbreviation used in this paper: RS, recognition structure. 
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Preparation and  Iodination  of IgG from  Anti-Alloantisera.--Crude  gamma globulin was 
precipitated from whole serum by dialysis against sodium sulfate  (4). The final precipitate 
was dissolved in 0.015 ~  potassium phosphate buffer, pH 8.0, and dialyzed overnight against 
the same buffer.  After removal of a  small precipitate by centrifugation, the protein solution 
(10-20  mg/ml) was applied to a  2.5  X  40  cm diethylaminoethyl cellulose  column  (Serva, 
Heidelberg, Germany) equilibrated with the above buffer.  Elution was carried out with an 
ionic strength gradient (0.015~).25 M) of the same buffer (5). The first major fraction to emerge 
was concentrated by vacuum dialysis,  sterilized by Millipore filtration, and stored at --20  ° C. 
Immunoelectrophoretic analysis showed this fraction to consist mainly of IgG. 
Four  IgG  preparations  (one  from each of  the anti-alloantisera listed in  Table  I)  were 
iodinated with 1%I by the chloramine T method (6) at the Schweizerisches Institut fttr Reaktor- 
forschung,  Wiirenlingen,  Switzerland.  Free  iodine  was  eliminated  by  passage  through  a 
Dowex  l-X8 C1- form column. The specific activities were: 0.93 mCi/mg for anti-(DA anti- 
BN),  0.83 mCi/mg for anti-(BN anti-DA), 2.0  mCi/mg for anti-(DA anti-Lewis), and 2.0 
mCi/mg for anti-(Lewis anti-DA). 
TABLE  I 
Anti-Alloantisera  Used in the Present Experiments 
Alloantiserum injected  as  Animals immunized 
antigen  Anti-alloantiserum obtained 
DA anti-BN  (DA X  BN)F1  Anti-(DA anti-BN) 
BN anti-DA  (DA X  BN)F1  Anti-(BN anti-DA) 
DA anti-Lewis  (DA M Lewis)Fl  Anti-(DA anti-Lewis) 
Lewis anti-DA  (DA X  Lewis)F1  Anti-(Lewis anti-DA) 
Upon receipt of  the  iodinated preparations from Wiirenlingen, they were immediately 
passed through a  2.5  X  90 cm column of Sephadex G-200 (Pharmacia Fine Chemicals, Inc., 
Uppsala,  Sweden). A  small amount  of aggregated material which came  off with  the void 
volume and some radioactivity appearing in the small molecular region were discarded. The 
main radioactive peak behaved like a  7S globulin molecule.  Gel filtration was repeated after 
3 wk, again permitting separation of some radioactivity in the small molecular region.  The 
four preparations gave satisfactory results during 3-5 wk, after which time they seemed to 
lose their specificity in a rather abrupt manner. 
The anti-alloantibodies were monitored through the various steps of preparation with the 
PAR  test  (1,  2).  For  instance, serum anti-(BN anti-DA)  had a  receptor-blocking titer as 
measured by the PAR test of 1 : 200,000. The IgG fraction after ion exchange chromatography 
(10 mg/ml of protein) displayed a  titer of 1:128,000.  The iodinated fraction (2 mg/ml)  re- 
vealed a  titer of 1:4000. 
Absorption of Iodlnated Anti-Alloantibodies with F1 Cells.--Before  being used in any of the 
tests to be described, the radioactive anti-alloantibodies were absorbed with spleen cells from 
F1 hybrids of the same cross  which had produced the anti-alloantibody. For instance, the 
iodinated anti-(BN anti-DA) was absorbed three times with 2  X  109  (BN  X  DA)F1 spleen 
cells/mg of iodinated protein at 37°C  for 30  min. This procedure was intended to remove 
renmants  of  the  alloantiserum used  for immunization  (in  this case BN  anti-DA)  and  to 
eliminate those iodinated molecules having the highest nonspecific affinity for lymphoid cells. 
Alloantibody-Coated Red Blood Cells.--Equal  volumes of a suspension containing 250 X  106 
fresh, washed (SX) rat red blood cells/ml of the proper type and of undiluted, inactivated 
alloantibody of the corresponding specificity were mixed and incubated for 30 rain at 37°C. 
The coated cells were washed three times with saline  (phosphate-buffered saline,  pH 7.2) at 
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Normal Lymphoid  Cell Suspe~sions.--These  were prepared from lymph nodes and spleens 
according to a  standard  procedure  (3). Lymphoid cells were washed three times at 130 g for 
8 min in Basal Medium Eagle (Laboratoires Eurobio, Paris,  France)  and were counted in a 
hemacytometer under phase contrast. Cell viability, as judged by the ability to exclude trypan 
blue,  was at least 95%. 
General Procedure for Determining the Reaction between Iodlnated  Anti-Alloantibody  and 
Cells.--l-ml aliquots of antigen (either coated red blood cells, usually 250 X  10S/ml, or normal 
lymphoid cells, usually 50 X  10S/ml) were distributed into 5-10 parallel 85 X  10 mm tubes. 
Radioactive reagent was added in a volume of 0.1 ml usually containing between 3 and 4 X  105 
cpm of 125I. The reaction between particulate antigen and radioactive anti-alloanfibody was 
allowed to proceed at room temperature for 60 min. The tubes were then centrifuged at 130 
g for 8 min and the supernatant  was sucked off, leaving approximately 0.05 ml and the cell 
sediment behind. The cells were resuspended in 1 ml of Basal Medium Eagle by touching the 
tubes to a  Vortex mixer (Scientific  Instruments,  Inc., Springfield,  Mass.), and 3 ml of Basal 
Medium were added  to the suspension.  The cells were again sedimented at 130 g for 8 min. 
This washing procedure was repeated for a  total of six times.  The last cell sediment was re- 
suspended in 2 ml of saline and  the cell suspension  was poured into plastic tubes  (Packard 
No.  6001098)  fitting  the  gamma  counter. 
Radioactivity Measurements.--A  Packard Auto-Gamma spectrometer model 3380 (Packard 
Instrument Co., Downers Grove, Ill.) equipped with a  1~  X  2 inches sodium iodide crystal 
was  used.  The counter was  calibrated with  the aid  of a  13~Cs standard.  Lower and  upper 
discriminator settings were 10 and 100 kev, respectively. Background levels (usually between 
80 and 200 cpm) were subtracted from the sample counts. Results are indicated as means ± 
standard  error. 
RESULTS 
(a)  Interaction  between  Iodinated  Anti-Alloantibody  and  Alloantibody-Coated 
Red Cells.--To test whether  the immunization  procedure  had,  in fact, induced 
the formation of inununoglobulin molecules capable of reacting with the antigen 
employed,  an  assay  had  to  be  arranged  in  which  alloantibody  (considered  as 
an  antigen)  was  allowed  to  interact  with  iodinated  anti-alloantibody.  Since 
both partners  in this reaction were immunoglobulins,  the Farr technique or its 
derivatives could not  be employed.  Rather,  use  was  made of the unique  anti- 
body character of the antigen by allowing it to coat rat red cells of appropriate 
histocompatibility  phenotype.  For  instance,  Lewis  red  cells  were  incubated 
with BN anti-Lewis serum (as indicated in Materials and Methods) ; the coated 
red cells were then brought into contact with radioactive anti-(BN anti-Lewis) 
or with  radioactive  anti-(Lewis  anti-BN).  The  amount  of  radioactivity  fixed 
by  the  coated red  cells was  determined  after  thorough  washing.  The  outcome 
of an experiment in which  the concentration  of alloantiserum  used  to coat the 
red cells was varied is shown in Table II. 
Experiments  using  the other two labeled  anti-antisera  (see Table I)  yielded 
similar results. The radioactive label was preferentially fixed by red cells which 
had been coated with the aUoantibody used to immunize  the anti-alloantibody 
donors.  Coating  with  an  alloantiserum  dilution  of  1:2  or  1:10  did  not  make 
much  difference;  alloantiserum  at  1:100  dilution  was  apparently  insufficient. 
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(b)  Specificity  of Interaction  between  Alloantibody  and  Iodinated  Anti-Allo- 
antibody.--The  three  rat  strains used  differ  at  major histocompatibility loci 
(7). Although the exact specificities involved have been less extensively studied 
than in the mouse, several specificities are known to exist, some of which are 
unique for some strains, whereas others are shared by two or more strains (8). 
Therefore, it was interesting to see to what extent an anti-alloantiserum react- 
ing with its  "proper"  antigen would cross-react with  a  "wrong"  antigen  of 
TABLE  II 
Fixation of Iodinated A nti-Alloantibody by Alloantibody-Coated Red Cells 
Radioactivity  (cpm)  Antigen*  Radioactive reagent added  fixed by antigens 
Lewis anti-DA 1:2  7108 4-  565 
Lewis anti-DA 1:10  Anti-(Lewis anti-DA)  5804 4-  577 
Lewis anti-DA 1:100  1332 4-  95 
Normal Lewis serum 1:2  1173 4-  137 
Lewis anti-DA 1:2  1766 4- 331 
Lewis anti-DA 1  : 10  Anti-(DA anti-Lewis)  734  4-  76 
Lewis anti-I)A 1:100  611  4-  123 
Normal Lewis serum 1:2  822  4-  92 
DA anti-Lewis 1:2  1592 4-  200 
I)A anti-Lewis 1  : 10  Anti-(Lewis anti-DA)  2030 4- 467 
DA anti-Lewis 1  : 100  1230 4-  55 
Normal DA Serum 1:2  1641 4-  110 
DA anti-Lewis 1:2  8447 4-  920 
DA anti-Lewis 1 : 10  Anti-(DA anti-Lewis)  8452 4-  799 
DA anti-Lewis 1:100  1622 4-  282 
Normal DA serum 1:2  1906 4-  304 
* Rat red cells coated with alloantibody. DA cells were coated with Lewis anti-DA and 
Lewis cells were coated with ])A anti-Lewis at the indicated concentrations. 
:~ Mean 4- standard error. 
similar alloantibody specificity. Table III gives an example of such an experi- 
ment. The two radioactively labeled anti-alloantibodies, anti-(DA anti-Lewis) 
and  anti-(Lewis anti-DA), were  reacted  with  four  al]oantibodies (considered 
as  antigens), namely: DA anti-Lewis and BN  anti-Lewis fixed  on Lewis  red 
cells, and Lewis anti-DA and BN anti-DA fixed on DA red  cells. 
The  highest  amount of  radioactivity was  always bound by  the  "correct" 
alloantibody,  i.e.,  that  used  for  immunizing the  anti-alloantibody donors. 
However,  substantial amounts of radioactivity were  also fixed by other allo- 
antibodies of  like  specificity. Thus,  whereas  red  cells  coated  with  DA  anti- 
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cells coated with  BN  anti-Lewis still fixed close  to  3500  counts  of  the  same 
reagent.  These differences were statisticallv significant. 
It appears clearly from Table III that the important point was similarity of 
combining  specificity of  two  alloantibodies, not  similarity of  origin.  For  in- 
stance,  BN  anti-DA  fixed  substantial  amounts  of  radioactivity  from  anti- 
(Lewis anti-DA), but BN  anti-Lewis did not. 
(c) [n,  teraclion between Iodinated Anti-Alloantibody and Normal Rat Lymphoid 
Cells.--Most immunological theories demand that recognition of foreign histo- 
compatibility antigens be a function of "receptors" or "recognition structures" 
(RS)  located on  lymphoid cells. It has  frequently  been  postulated  that  such 
TABLE  III 
Specificity  of Iodinated  A nti-A lloantibody 
Radioactivity (cpm) fixed  Antigen*  Radioactive reagent added  by antigen+  + 
Lewis anti-DA  7517  +  750 
DA anti-Lewis  1010 4-  132 
BN anti-DA  Anti-(Lewis anti-DA)  6613  4-  501 
BN anti-Lewis  1474 =t=  212 
Lewis anti-DA  1310 -4-  120 
DA anti-Lewis  Anti-(DA anti-Lewis)  11,042  -4-  1305 
BN anti-DA  1557  4-  174 
BN anti-Lewis  3429  4-  753 
* Rat red cells coated with alloantibody. Lewis anti-DA and BN anti-DA were used at 
1  : 10 dilution to coat DA red cells, and DA anti-Lewis and BN anti-Lewls were used at 1  : 10 
dilution to coat Lewis red cells. 
Mean =t= standard error. 
recognition  structures  should  bear  some  resemblance  to  circulating  alloanti- 
bodies. Since,  as shown  above, our iodinated reagents did react with alloanti- 
body of the proper specificity, a  direct test for the presence of RS on normal 
lymphoid cells seemed feasible. 
Normal 13,~nphoid  cells (from lymph nodes and spleens) were left in contact 
with  radioactive  anti-alloantibody  and  washed  thoroughly,  and  the  radio- 
activity which they had taken up was determined (see Materials and Methods). 
Table IV shows an example in which the numbers of lymphoid cells was varied, 
the input radioactivity being kept constant. 
The  amount  of radioactivity fixed by the correct lymphoid cells was much 
higher  than  the  amount  absorbed by  the  wrong  cells,  and  it increased  with 
increasing  cell  dose.  Thus,  the  radioactive anti-(BN  anti-DA),  presumed  to 
have activity against receptors for DA antigens, was fixed by BN  cells, which 
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not by DA cells, which cannot carry receptors for their own histocompatibility 
phenotype. 
(d)  Specificity  of Interaction  between Normal  Lymphoid  Cells  and Iodinated 
Anti-AUoantibody.--The same considerations made in section b with respect to 
alloantibodies of like specificity but of different origin apply for lymphoid cells. 
Thus, DA cells carry RS(Lewis) and are  therefore capable of  fixing anti-(DA 
anti-Lewis)  [=  anti-RS(Lewis)].  However,  BN  cells  also  carry RS(Lewis), 
TABLE  IV 
Fixation of Iodinated Anti-Alloantibody by Normal Rat Lymphoid Cells 
Radioactivity (cpm)  Antigen*  Radioactive reagent added  fixed by antigen:~ 
25 X  106 BN cells  4373 4- 222 
50 X  106 BN cells  9573 4-  764 
75 X  106 BN cells  Anti-(BN anti-DA)  15,903  -4-  194 
100 X  106 BN cells  20,785  4- 373 
25 X  106 BN cells  1443 4-  226 
50 X  106 BN cells  961  4-  77 
75 X  106 BN cells  Anti-(DA anti-BN)  1038 +  196 
100 X  106 BN cells  1154 4-  147 
25 X  106 DA cells  1166 ±  93 
50 X  106 DA cells  1410 +  111 
75 X  106 DA cells  Anti-(BN anti-DA)  1454 4-  156 
100 X  106 DA cells  1419 +  162 
25 X  106 DA cells  3593 -4- 227 
50 )<  106 DA cells  7533 ±  203 
75 X  106 DA cells  Anti-(DA anti-BN)  11,199  4-  574 
100 X  l0 G  DA cells  15,143  4-  600 
* Normal lymphoid ceils from lymph nodes and spleen. 
:~ Mean 4- standard error. 
although  RS(Lewis)  on BN  cells  is  probably not  identical to RS(Lewis)  on 
DA  cells. A  partial identity between these  two  recognition structures of like 
specificity should reveal itself by a  certain amount of cross-reaction with the 
radioactive  anti-(DA anti-Lewis). Table V  contains an  example  of  such  an 
experiment. 
Whereas Lewis cells fixed about 12,000 counts of anti-(Lewis anti-DA), BN 
cells absorbed approximately 8000 counts, a quantity well in excess of the 1600 
counts taken up by DA cells, which must be entirely devoid of any RS for DA 
antigens. 
The behavior of F1 cells was particularly revealing. Thus, (Lewis X  DA)F1 878  ANTI-ALLOANTISERUM  AND  RECEPTORS 
cells should not be  able to  bind radioactive anti-(BN anti-DA), since the  F: 
cells carry the DA  antigen and should  therefore  lack RS(DA).  On the other 
hand, these same (Lewis X  DA)Fx cells should be capable of fixing some radio- 
active anti-(DA anti-BN), since they must have RS(BN). As shown in Table 
VI, this expectation was fulfilled. 
TABLE  V 
Specificity of Cellular Receptors  for Iodinated A nti-A lloantibody 
Radioactivity (cpm) fixed  Antigen*  Radioactive reagent added  by antigen:~ 
Lewis cells  12,289 4-  796 
DA cells  Anti-(Lewis anti-DA)  1601 -4-  50 
BN cells  8168 ±  443 
Lewis cells  1632 4-  107 
DA cells  Anti-(DA anti-Lewis)  13,436  4-  856 
BN cells  10,036  4-  1544 
* 50 N  10 ~ normal lymphoid cells from lymph nodes and spleen. 
;~ Mean 4- standard error. 
TABLE  VI 




(Lewis X DA)F1 cells 
BN cells 
DA cells 
(Lewis X DA)Fa cells 
Radioactivity (cpm)  Radioactive reagent added  fixed by antigens 
6111 4-  897 
Anti-(BN anti-DA)  1345 -4-  131 
1245 4-  116 
Anti-(DA anti-BN  t 
787  -4-  69 
3345 -4-  279 
2970 ±  359 
* 50 X  106 normal lymphoid cells from lymph nodes and spleen. 
Mean +  standard error. 
(e) Absorption of a Specific Subpopulation from Iodiuated A nti-Alloantibody.-- 
Since the  radioactive input was  always very  large  when  compared  with  the 
radioactivity fixed by cells, it seemed important to show that the uptake of this 
small fraction was actually specific. This was done by serial absorption experi- 
ments: A radioactive input of approximately 400,000 cpm of anti-alloantibody 
was absorbed first with 50  X  106 normal lymphoid cells; the supernatant was 
again absorbed with 50 X  106 fresh cells, and this procedure was repeated two 
more times. The radioactivities fixed by each lot of cells as well as that of the 
last supernatant were determined. Table VII shows the  results of two experi- 
ments. After four absorption cycles the supernatant still contained more than HANS  BINZ  AND  JEAN  LINDENMANN  879 
90%  of  the  initial  counts.  However,  the  specific  counts  had  been  largely  re- 
moved,  as  shown  by  the fact  that  the fourth  batch  of  lymphoid  cells was  no 
longer able to fix significant amounts  of specific radioactivity. 
TABLE  VII 
Absorption of Iodlnated Anti-Alloantibody by Lymphoid Cells 
Radioactivity (cpm)  Antigen used for absorption*  Radioactive reagent added  fixed by antigen* 
First batch of Lewis cells 
Second batch of Lewis cells 
Third batch of Lewis cells 
Fourth batch of Lewis cells 
First batch of DA cells 
Second batch of DA cells 
Third batch of DA cells 
Fourth batch of DA cells 
Anti-(Lewis anti-DA) 
Supernatant of first absorption 
Supernatant of second absorption 
Supernatant of third absorption 
Anti-(DA anti-Lewis) 
Supernatant of first absorption 
Supernatant of second absorption 
Supernatant of third absorption 
9036  4-  1319 
2564  ±  695 
1432  4-  370 
2696  ±  541 
22,891  4-  6015 
13,654  4-  2107 
9893  4-  1986 
6668  -4-  687 
* 50 )<  106 normal lymph node and spleen cells per batch. 
:~ Mean 4- standard error. 
TABLE  VIII 
Absorption of Iodinated A nti-Alloantibody by Lymphoid Cells. Parallel Decrease o/Binding  by 
Lymphoid Cells and  by  Alloantibody-Coated Red  Cells 
Antigen used for 
absorption*  Radioactive reagent added 
Radioactivity (cpm):~  fixed by 
Lymphoid cells  Coated cells§ 
First batch of DA  Anti-(DA anti-Lewis)  10,914  -4-  1156  -- 
cells 
Second batch of DA  Supernatant of first absorp-  6634  4-  411  12,252  -4-  91 
cells  tion 
Third batch of DA  Supernatant of second ab-  2413  4-  390  2915  4-  180 
cells  sorption 
Fourth batch of DA  Supernatant of third ab-  1240  4-  78  1109  4-  143 
cells  sorption 
Supernatant of fourth ab-  --  1303  4-  18 
sorption 
* 50 X  106 normal lymph node and spleen cells per batch. 
:~  Mean -4- standard error. 
§ 250 X  106 Lewis red cells coated with DA anti-Lewis. 
(  f) Identity of the Radioactive Subpopulation Fixed by Lymphoid Cells with that 
Absorbed by Alloantibody.--An  experiment  similar  to  the one shown  on Table 
VII was used to answer the following question: Are the labeled molecules taken 
up by lymphoid  cells the same as  those which can be fixed by red cells coated 
with  alloantibody?  Iodinated  anti-(DA  anti-Lewis)  was  absorbed  with  four 
batches of 50 X  106 DA cells each. An aliquot of each supernatant  was reacted 880  ANTI-AI.LOANTISERUM AND  RECEPTORS 
with Lewis red cells coated with DA anti-Lewis. The results are shown in Table 
VIII. 
The radioactivity which could still be fixed by alloantibodv-coated red cells 
diminished in parallel to that which had affinity for lymphoid cells. It thus ap- 
peared that the same molecules were involved in both reactions. 
The  same  phenomenon  could  be  shown  in  a  slightly" different experiment. 
Here  lymphoid cells of type I)A were reacted with radioactive anti-(DA anti- 
Lewis)  in  the  presence  of a  1:10  dilution  (presumably' a  large excess)  of DA 
anti-Lewis. The  radioactivity fixed by the DA cells was  substantially reduced 
in comparison with the control where a  1 : 10 dilution of normal DA serum had 
been added (Table IX). Tables VIII and IX indicate that lymphoid cells of the 
TABLE  IX 
Inhibition by Free  Alloanlibody of lhe  Reaclion  between Iodinaled Anli-Alloantibody and 
Lymphoid C'ells 
Reaction  mixture  Radioactivity (cpm) 
Antigen*  fixed by cells§ 
Radioactive reagent +  Serum added~ 
DA cells  Anti-(DA anti-Lewis)  q- Normal DA  10,073  -t-  1462 
I)A cells  Anti-(DA anti-Lewis)  -!- DA anti-Lewis  1474 =t=  84 
Lewis cells  Anti-(Lewis anti-DA) +  Normal Lewis  4852  4-  1292 
Lewis cells  Anti-(Lewis anti-DA) q- Lewis anti-DA  1216 -t-  115 
* 50 X  10 6 normal lymph node and spleen cells. 
{ A 1:10 dilution of heat-inactivated serum was added to the reaction mixture. 
§ Mean 4- standard error. 
proper type and  circulating alloantibodv of the proper specificity compete for 
the same radioactive anti-alloantibody. 
DISCUSSION 
Two technical factors may have contributed to the success of our experiments. 
The first was the use of rats as experimental animals. The iodination of anti- 
bodies  of  mouse  origin  reportedly yields erratic  results  (Dr.  G.  M.  Iverson, 
personal  communication).  Preliminary  experiments  with  iodinated  rat  allo- 
antibodies had convinced us that they were easy to prepare without undue loss 
of activity. We had therefore reasons to hope that  the  iodination of anti-allo- 
antibodies  from  rats  would  not  present  intractable  difficulties. In  fact,  this 
aspect of our work proved surprisingly- unproblematic. 
The  second factor  was  the  possibility" of exhaustively absorbing our  radio- 
active reagents with  lymphoid cells of F1 origin before using them in tests.  F1 
cells must be chemically very, similar to the parental lymphoid cells used in the 
actual  experiments,  and  yet  they- lacked the  specific recognition structure  in 
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unnecessary, since the serum must have already been absorbed in vivo by the 
cells of the  very animal  which produced it.  However, remnants of the  allo- 
antibody used to immunize F1 animals might still have been present at the time 
of bleeding. Furthermore, some iodinated molecules could conceivably have a 
propensity for nonspecific adsorption onto lymphoid cells of any kind, and these 
were conveniently removed by Fs cells. 
One may ask why alloantibodies should be such good antigens in the first 
place.  A  possible  answer is  that  their  antibody nature  endows  them with  a 
"homing device" directing them at strategically important points of the immune 
system of the inoculated F1 host. 
Could our findings be explained by assuming that our radioactive reagents 
were  directed  at  histocompatibility  antigens?  This  is  most  unlikely.  Rat 
histocompatibility antigens  are inherited codominantly (8), hence F1 animals 
should  be  incapable  of  forming  anti-histocompatibility  antibodies  against 
parental antigens. One would also have to postulate that, for instance, Lewis 
red  cells  coated  with  DA  anti-Lewis  exhibited  the  same  histocompatibility 
antigen as normal DA lymphoid cells, a rather elaborate assumption. 
Could the existence of allotypes account for our findings? The answer again 
is  no.  An  F~  animal  should  not  be  capable  of producing  antibodies  against 
parental  allotypes, since  these are inherited codominantly (9  11).  That allo- 
types were not involved could also be shown by experiments such as those sum- 
marized in Table III: red cells  coated with Lewis  anti-DA  absorbed  a  large 
amount of radioactive anti-(Lewis anti-DA), whereas red cells coated with BN 
anti-Lewis  absorbed  little  of the  same  reagent; yet Lewis and  BN immuno- 
globulins share the same allotype (10,  11). 
To simplify further discussions,  the actual names of inbred rat strains con- 
cerned will be reduced to A, B, and C. RS stands for recognition structure, A 
RS(B) represents that recognition structure which enables A cells to recognize 
the foreignness of the histocompatibility complex B. Similarly, A anti-B is an 
alloantiserum made by an animal A in response to a  skin transplant from B. 
The  antisera  which  were  radioactively labeled  were  induced  by injecting A 
anti-B serum or B anti-A serum into (A X  B)F1 animals. The activity obtained 
was an anti-alloantiserum called anti-(A  anti-B)  and anti-(B anti-A),  respec- 
tively (Table I). 
As expected, anti-(A anti-B) was preferentially fixed by rat red cells of type B 
coated with  A  anti-B  antibody  (Table II).  Absorption  of A  anti-B  onto B 
target cells apparently did not impede its capacity to react with anti-(A anti-B). 
This perhaps  offers an  explanation for the  recently reported failure of anti- 
receptor sera to inhibit cytotoxicity of alloantibodies (12). It had been shown 
previously, with the aid of the PAR test, that A anti-B must be antigenically 
similar  to A  RS(B)  (1).  This was  shown  again  bv  the  present  experiments: 
Anti-(A  anti-B)  was  preferentially fixed  by  lymphoid  cells  of  type  A,  and 
anti-(B  anti-A)  was  preferentially taken  up  by  cells  B,  because  the  former 882  ANTI-ALLOANTISERUM  AND  RECEPTORS 
antibody represents anti-RS(B) and the latter anti-RS(A), respectively (Table 
IV).  Cells  of type C fixed a certain amount of both anti-(A anti-B) and anti- 
(B  anti-A)  (Table V). This was to be expected, since cells  of type C  contain 
both RS(A) and RS(B). However, it should be noted that RS(A) on cells C is 
different from RS(A) on cells B. Cells of type C can recognize on A cells only 
that  subset  of  histocompatibility  specificities  as  foreign  by  which  the  two 
strains,  A  and  C,  differ. This  is not,  in  general,  the  same  subset  by which 
strains A and B  differ. Therefore only partial cross-reactions can be expected 
between recognition structures of like specificity located on cells  of different 
histocompatibility type. 
A beautiful illustration of the principles involved is offered by the behavior 
of F~ cells: (A >(  C)F~ cells fixed anti-(A anti-B), whereas (B  >  C)F1  cells did 
not (Table VI). This can be easily understood: (A)<  C)F1  cells possess RS(B), 
but (B >(  C)F1 cells, having themselves the antigen B, cannot carry RS(B). 
From our absorption and inhibition experiments it appears that those radio- 
active molecules which were fixed by appropriate lymphoid cells were the same 
as  those  fixed  by  alloantibody-coated red  cells  (Tables  VIII  and  IX).  We 
interpret this to mean that anti-(A anti-B) specifically binds to both A anti-B 
and to A RS(B).  Symbolically, one could therefore write: anti-(A  anti-B)  = 
anti-A RS(B). 
Hence there must exist an antigenic similarity between circulating alloanti- 
body A anti-B and the corresponding cellular receptor, A RS(B). This idea has 
been expressed previously by stating that alloantibody and the corresponding 
recognition structure are of the same aliotype (13). 
The existence of antibodies directed against individual-specific determinants 
of other antibodies is well recognized (14-17).  These specificities are usually 
called idiotypes. The difference between idiotypes as observed by others and 
our present findings is that all alloantibodies of a given specificity, e.g. A anti-B, 
induce the same anti-(A anti-B) antibody, whereas ordinary antibodies can have 
different idiotypes even if they are of the same specificity (15). The similarity 
between  recognition  structure  and  circulating  alloantibody  probably  means 
that the antibodies appearing in the course of skin graft rejections are "true" 
copies of the receptors occurring in nonstimulated lymphoid cells. The aliotypic 
specificity therefore can be defined as an antigen characterizing all alloantibodies 
of a given specificity and the corresponding recognition structures (13). 
I t has been suggested by some that anti-(A anti-B) might consist of a complex 
of anti-B +  B. While this interpretation seems farfetched and is unlikely to be 
true on several counts (18), the present experiments were not designed with a 
view of proving or disproving it.  However, the ease with  which our anti-RS 
activity could be iodinated and its behavior in gel filtration and ion exchange 
chromatography strongly suggest that the activity resides in a  bona fide im- 
munoglobulin molecule. 
The present paper is a first forage into an area which promises vast oppor- HANS BINZ  AND  JEAN  LINDENMANN  883 
tunities for research. It will be necessary to delineate clearly the extent of cross- 
reactions between recognition structures of like specificities, and  to correlate 
these  with  the  histocompatibility  types  involved.  It  might  be  possible,  by 
saturating  the  receptors  on  lymphoid  cells,  to  estimate  their  numbers  and 
distribution. One of the questions which are of particular actuality concerns the 
nature of the lymphoid cells that fix the labeled anti-alloantibody. Are they B 
cells or T  cells?  The alloantibodies used as immunogens are supposedly of B 
cell origin. However, the recognition of histocompatibility antigens is usually 
attributed  to  T  cells.  Preliminary experiments suggest  that  "educated"  rat 
thymocytes bind much more of our radioactive reagents than do normal lymph- 
oid cells (H. Binz and J. Lindenmann, unpublished data). A definite proof that 
the lymphoid cells involved are T  cells would be important, since it might shed 
light on the hitherto elusive nature of the T  cell receptor. 
SUMMARY 
Rat alloantisera of the following specificities were obtained after single skin 
graft rejection: DA anti-BN, BN anti-DA, DA anti-Lewis, and Lewis anti-DA. 
Anti-alloantibodies  were  raised  by  injecting  the  first  two  alloantisera  into 
(DA ;< BN)F1 hosts and the last two alloantisera into (DA)< Lewis)F1 hosts. 
In  this manner,  four anti-alloantisera were raised:  anti-(DA  anti-BN),  anti- 
(BN  anti-DA),  anti-(DA  anti-Lewis),  and anti-(Lewis anti-DA).  From  each 
anti-alloantiserum a  gamma globulin fraction was prepared and trace labeled 
with 1251. 
The labeled anti-alloantibodies could be shown to be fixed preferentially by 
red  cells coated with  the  alloantibody used  to induce them. They were also 
preferentially fixed by normal rat lymphoid cells presumed to carry recognition 
structures similar to alloantibody. For instance, anti-(DA anti-BN) was fixed 
by BN  red cells coated with DA anti-BN and by normal DA lymphoid cells 
presumed to carry RS(BN). Conversely, anti-(BN anti-DA) was fixed by DA 
red cells coated with BN anti-DA and by normal BN lymphoid cells,  carrying 
RS(DA). 
Absorption and inhibition experiments showed that alloantibodies and normal 
lymphoid cells compete for the same labeled anti-alloantibodies. We conclude 
that  cellular receptors and  circulating alloantibody are  antigenically similar: 
They have the same aliotype. 
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